{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-039348","form_type":"8-K","ticker":null,"cik":"0000764195","company_name":"VBI Vaccines Inc/BC","filed_at":"2023-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.967911+00:00","generated_at":"2026-06-08T22:52:33.802084+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"VBI Vaccines receives Nasdaq deficiency notice for bid price below $1.00","bullets":["Nasdaq letter dated Nov 1, 2023; stock closed below $1.00 for 30 consecutive business days (Sept 19 – Oct 31).","Company has 180-day compliance period until April 29, 2024 to regain minimum bid price.","Must achieve closing bid of $1.00 or more for at least 10 consecutive business days during the period.","If not cured, may be eligible for additional 180 days if it meets other listing standards and plans a reverse split.","No immediate impact on listing; shares continue trading on Nasdaq during compliance period."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-039348","json":"https://secwatch.observer/filing/0001493152-23-039348.json","markdown":"https://secwatch.observer/filing/0001493152-23-039348.md","text":"https://secwatch.observer/filing/0001493152-23-039348.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/764195/000149315223039348/0001493152-23-039348-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/764195/000149315223039348/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T22:52:33.802084+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3f5e0681c1c04797cf3edace1acca1596d6e1b7c","claim":"VBI Vaccines Inc/BC received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"November 1, 2023, VBI Vaccines Inc. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (the “Staff”) indicating that, based upon the closing bid price of the Company’s common shares for the 30 consecutive business day period between September 19, 2023, through October 31, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market (“Nasdaq”) pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/764195/000149315223039348/0001493152-23-039348-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"noncompliance notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}